These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 39192329)

  • 1. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.
    Wang H; Fleishman JS; Cheng S; Wang W; Wu F; Wang Y; Wang Y
    Mol Cancer; 2024 Aug; 23(1):177. PubMed ID: 39192329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma.
    Sun L; Cao H; Wang Y; Wang H
    Biol Direct; 2024 Sep; 19(1):80. PubMed ID: 39267124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects.
    Cao MY; Zhang ZD; Hou XR; Wang XP
    Anticancer Agents Med Chem; 2024; 24(16):1182-1196. PubMed ID: 39021186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.
    Wang Y; Hu J; Wu S; Fleishman JS; Li Y; Xu Y; Zou W; Wang J; Feng Y; Chen J; Wang H
    Signal Transduct Target Ther; 2023 Dec; 8(1):449. PubMed ID: 38072908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming cancer chemotherapy resistance by the induction of ferroptosis.
    Wang Y; Wu X; Ren Z; Li Y; Zou W; Chen J; Wang H
    Drug Resist Updat; 2023 Jan; 66():100916. PubMed ID: 36610291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs.
    Zhang Q; Fan X; Zhang X; Ju S
    J Transl Med; 2023 Jul; 21(1):514. PubMed ID: 37516888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of ferroptosis by non‑coding RNAs in cancers: Potential biomarkers for cancer diagnose and therapy.
    Gong H; Li Z; Wu Z; Lian G; Su Z
    Pathol Res Pract; 2024 Jan; 253():155042. PubMed ID: 38184963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis.
    Zhang Y; Xie J
    Biomed Pharmacother; 2024 Mar; 172():116235. PubMed ID: 38308967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance.
    Rezakhani L; Salmani S; Eliyasi Dashtaki M; Ghasemi S
    Curr Mol Med; 2024; 24(8):951-961. PubMed ID: 37592772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.
    Zhang X; Wang L; Li H; Zhang L; Zheng X; Cheng W
    Cell Death Dis; 2020 Jul; 11(7):580. PubMed ID: 32709863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.
    Lee J; Roh JL
    Cell Oncol (Dordr); 2023 Dec; 46(6):1605-1623. PubMed ID: 37438601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigating the autophagic landscape: Epigenetic modulation in gastrointestinal cancer.
    Ramoni D; Carbone F; Montecucco F
    World J Gastroenterol; 2024 Aug; 30(31):3628-3634. PubMed ID: 39192999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity.
    Shan C; Liang Y; Wang K; Li P
    Biomed Pharmacother; 2023 Sep; 165():115053. PubMed ID: 37379641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets.
    Nejadi Orang F; Abdoli Shadbad M
    Cell Death Dis; 2024 May; 15(5):357. PubMed ID: 38778030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.